Cargando…
Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants
Coronavirus disease (COVID-19) can cause critical conditions that require efficient therapeutics. Several medicines are derived from plants, and researchers are seeking natural compounds to ameliorate the symptoms of COVID-19. Viral enzymes are popular targets of antiviral medicines; the genome of c...
Autores principales: | Park, Junsoo, Park, Rackhyun, Jang, Minsu, Park, Yea-In, Park, Yeonjeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Microbiological Society of Korea
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795716/ https://www.ncbi.nlm.nih.gov/pubmed/35089586 http://dx.doi.org/10.1007/s12275-022-1499-z |
Ejemplares similares
-
AMPK inhibitor, compound C, inhibits coronavirus replication in vitro
por: Jang, Minsu, et al.
Publicado: (2023) -
Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model
por: Park, Rackhyun, et al.
Publicado: (2021) -
Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases
por: Park, Junsoo, et al.
Publicado: (2021) -
Elevated Levels of CTRP1 in Obesity Contribute to Tumor Progression in a p53-Dependent Manner
por: Park, Rackhyun, et al.
Publicado: (2021) -
LNX1 Contributes to Cell Cycle Progression and Cisplatin Resistance
por: Jang, Minsu, et al.
Publicado: (2021)